-
1
-
-
32144450966
-
Facing the diabetes epidemic - Mandatory reporting of glycosylated hemoglobin values in New York City
-
Steinbrook R: Facing the diabetes epidemic - mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 2006;354:545-548.
-
(2006)
N Engl J Med
, vol.354
, pp. 545-548
-
-
Steinbrook, R.1
-
2
-
-
0003717478
-
-
(accessed January 2, 2008, last modified February 2, 2006)
-
Centers for Disease Control: National diabetes fact sheet, United States 2005. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2005.pdf (accessed January 2, 2008, last modified February 2, 2006).
-
National Diabetes Fact Sheet, United States 2005
-
-
-
3
-
-
56349167188
-
-
accessed January 2, 2008, page last reviewed March 26, 2007
-
Centers for Disease Control: Diabetes data and trends. http://www.cdc.gov/diabetes/statistics/incidence/fig1.htm (accessed January 2, 2008, page last reviewed March 26, 2007).
-
Diabetes Data and Trends
-
-
-
4
-
-
14644395218
-
-
National Center for Health Statistics: US Department of Health and Human Services, (accessed January 2, 2008, page last updated December 31, 2007)
-
National Center for Health Statistics: Deaths - leading causes (2005). US Department of Health and Human Services, Centers for Disease Control. http://www.cdc.gov/nchs/fastats/lcod.htm (accessed January 2, 2008, page last updated December 31, 2007).
-
(2005)
Deaths - Leading Causes
-
-
-
5
-
-
69349087242
-
-
accessed January 2, 2008
-
National Kidney Foundation: Diabetes and kidney disease. http://www.kidney.org/kidneydisease/diabetesckd/index.cfm (accessed January 2, 2008).
-
Diabetes and Kidney Disease
-
-
-
6
-
-
0037228105
-
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
-
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12. (Pubitemid 36043346)
-
(2003)
American Journal of Kidney Diseases
, vol.41
, Issue.1
, pp. 1-12
-
-
Coresh, J.1
Astor, B.C.2
Greene, T.3
Eknoyan, G.4
Levey, A.S.5
-
8
-
-
67649415439
-
Examination of outcomes and costs of care among patients with chronic kidney disease and secondary hyperparathyroidism
-
Kalantar-Zadeh K, Marx SE, Schumock G, Bocuzzi SJ, Blount A, Sterz R, Melnick JZ, Williams LA: Examination of outcomes and costs of care among patients with chronic kidney disease and secondary hyperparathyroidism. J Am Soc Nephrol 2006;17:647A.
-
(2006)
J Am Soc Nephrol
, vol.17
-
-
Kalantar-Zadeh, K.1
Marx, S.E.2
Schumock, G.3
Bocuzzi, S.J.4
Blount, A.5
Sterz, R.6
Melnick, J.Z.7
Williams, L.A.8
-
10
-
-
9444223856
-
End-stage renal disease-associated managed care costs among patients with and without diabetes
-
DOI 10.2337/diacare.27.12.2829
-
Joyce AT, Iacoviello JM, Nag S, Sajjan S, Jilinskaia E, Throop D, Pedan A, Ollendorf DA, Alexander CM: End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care 2004;27:2829-2835. (Pubitemid 39565045)
-
(2004)
Diabetes Care
, vol.27
, Issue.12
, pp. 2829-2835
-
-
Joyce, A.T.1
Iacoviello, J.M.2
Nag, S.3
Sajjan, S.4
Jilinskaia, E.5
Throop, D.6
Pedan, A.7
Ollendorf, D.A.8
Alexander, C.M.9
-
11
-
-
39749147588
-
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: Results from a US claims data analysis
-
DOI 10.1007/s10549-007-9601-0
-
Pelletier EM, Shim B, Goodman S, Amonkar MM: Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 2008;108:297-305. (Pubitemid 351311367)
-
(2008)
Breast Cancer Research and Treatment
, vol.108
, Issue.2
, pp. 297-305
-
-
Pelletier, E.M.1
Shim, B.2
Goodman, S.3
Amonkar, M.M.4
-
12
-
-
33947598628
-
Reduced mortality rates after intensive statin therapy in managed-care patients
-
DOI 10.1111/j.1524-4733.2006.00163.x
-
Fintel D, Joyce A, Mackell J, Graff J, Kuntze E, Ollendorf DA: Reduced mortality rates after intensive statin therapy in managed-care patients. Value Health 2007;10:161-169. (Pubitemid 46481143)
-
(2007)
Value in Health
, vol.10
, Issue.2
, pp. 161-169
-
-
Fintel, D.1
Joyce, A.2
Mackell, J.3
Graff, J.4
Kuntze, E.5
Ollendorf, D.A.6
-
13
-
-
33845700085
-
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
-
DOI 10.1038/sj.ki.5002009, PII 5002009
-
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:31-38. (Pubitemid 44967731)
-
(2007)
Kidney International
, vol.71
, Issue.1
, pp. 31-38
-
-
Levin, A.1
Bakris, G.L.2
Molitch, M.3
Smulders, M.4
Tian, J.5
Williams, L.A.6
Andress, D.L.7
-
14
-
-
2442587499
-
Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings
-
DOI 10.1093/ndt/gfh123
-
Dobrez DG, Mathes A, Amdahl M, Marx SE, Melnick JZ, Sprague SM: Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. Nephrol Dial Transplant 2004;19:1174-1181. (Pubitemid 38628138)
-
(2004)
Nephrology Dialysis Transplantation
, vol.19
, Issue.5
, pp. 1174-1181
-
-
Dobrez, D.G.1
Mathes, A.2
Amdahl, M.3
Marx, S.E.4
Melnick, J.Z.5
Sprague, S.M.6
-
15
-
-
33750425045
-
Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis
-
DOI 10.2165/00044011-200626110-00002
-
Rosery H, Bergemann R, Marx SE, Boehnke A, Melnick J, Sterz R, Williams L: Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis. Clin Drug Invest 2006;26:629-638. (Pubitemid 44641875)
-
(2006)
Clinical Drug Investigation
, vol.26
, Issue.11
, pp. 629-638
-
-
Rosery, H.1
Bergemann, R.2
Marx, S.E.3
Boehnke, A.4
Melnick, J.5
Sterz, R.6
Williams, L.7
-
16
-
-
38149138055
-
Pharmacoeconomic analysis of paricalcitol and calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis: Impact of hospitalizations and survival
-
Schumock GT, Arruda JA, Marx SE, Melnick JZ, Sterz R, Williams LA: Pharmacoeconomic analysis of paricalcitol and calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis: impact of hospitalizations and survival. J Med Econ 2007;10:393-409.
-
(2007)
J Med Econ
, vol.10
, pp. 393-409
-
-
Schumock, G.T.1
Arruda, J.A.2
Marx, S.E.3
Melnick, J.Z.4
Sterz, R.5
Williams, L.A.6
-
17
-
-
0042343804
-
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
-
DOI 10.1056/NEJMoa022536
-
Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-456. (Pubitemid 36910023)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.5
, pp. 446-456
-
-
Teng, M.1
Wolf, M.2
Lowrie, E.3
Ofsthun, N.4
Lazarus, J.M.5
Thadhani, R.6
-
18
-
-
33745210682
-
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
-
DOI 10.1038/sj.ki.5001514, PII 5001514
-
Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780. (Pubitemid 44215354)
-
(2006)
Kidney International
, vol.70
, Issue.4
, pp. 771-780
-
-
Kalantar-Zadeh, K.1
Kuwae, N.2
Regidor, D.L.3
Kovesdy, C.P.4
Kilpatrick, R.D.5
Shinaberger, C.S.6
McAllister, C.J.7
Budoff, M.J.8
Salusky, I.B.9
Kopple, J.D.10
-
19
-
-
44449113816
-
Vitamin D receptor activation and survival in chronic kidney disease
-
DOI 10.1038/ki.2008.35, PII KI200835
-
Kovesdy CP, Kalantar-Zadeh K: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 2008;73:1355-1363. (Pubitemid 351770491)
-
(2008)
Kidney International
, vol.73
, Issue.12
, pp. 1355-1363
-
-
Kovesdy, C.P.1
Kalantar-Zadeh, K.2
-
20
-
-
0002120165
-
Methodological issues in conducting pharmacoeconomic evaluations - Retrospective and claims database
-
Arnold RG, Kotsanos JG, Motheral B, Ramsey S, Crown W, Puder K, Hornbrook M, Wright A, Murray M: Methodological issues in conducting pharmacoeconomic evaluations - retrospective and claims database. Value Health 1999:2;82-87.
-
(1999)
Value Health
, vol.2
, pp. 82-87
-
-
Arnold, R.G.1
Kotsanos, J.G.2
Motheral, B.3
Ramsey, S.4
Crown, W.5
Puder, K.6
Hornbrook, M.7
Wright, A.8
Murray, M.9
|